Robert K Zeldin Insider Trading
Get free email notifications about insider trading for Robert K Zeldin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert K Zeldin. Robert K Zeldin is a EVP & Chief Medical Officer in ACCELERON PHARMA INC ($XLRN) and a Chief Medical Officer in MeiraGTx Holdings plc ($MGTX) and a Chief Medical Officer in Health Sciences Acquisitions Corp ($HSAC).
Address: 128 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Robert K Zeldin is an Insider
ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert K Zeldin: EVP & Chief Medical Officer
Holdings: 19,103 shares
Current Value: $453,505
Latest Transaction: Jan 29 2019
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Immunovant, Inc.
Trading Symbol: IMVTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert K Zeldin: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Dec 20 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MeiraGTx Holdings plc
Trading Symbol: MGTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert K Zeldin: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Jan 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert K Zeldin
Sentiment: All, XLRN, IMVT, MGTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2021 | MGTX | MeiraGTx Holdings ... | Zeldin Robert K | Chief Medical Offic ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 19 2021 | MGTX | MeiraGTx Holdings ... | Zeldin Robert K | Chief Medical Offic ... | Option Exercise | A | 16.43 | 40,000 | 657,200 | 40,000 | |
Aug 05 2020 | MGTX | MeiraGTx Holdings ... | Zeldin Robert K | Chief Medical Offic ... | Option Exercise | A | 13.24 | 150,000 | 1,986,000 | 150,000 | |
Dec 20 2019 | HSAC | Health Sciences Ac ... | Zeldin Robert K | Chief Medical Offic ... | Option Exercise | A | 7.86 | 380,325 | 2,989,355 | 380,325 | |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zeldin Robert K | EVP & Chief Medical ... | Option Exercise | A | 41.64 | 13,000 | 541,320 | 13,000 | |
Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zeldin Robert K | EVP & Chief Medical ... | Grant | A | 0.00 | 2,200 | 0 | 19,103 | 16.9 K to 19.1 K (+13.02 %) |
Jul 05 2018 | XLRN | ACCELERON PHARMA I ... | Zeldin Robert K | EVP & Chief Medical ... | Option Exercise | A | 47.33 | 85,511 | 4,047,236 | 85,511 |